Varinder Jeet - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Varinder Jeet

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

The Journal of Experimental Medicine|May 19, 2010

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigensSarah L Jongbloed, Andrew J Kassianos, Kylie J McDonald, et al.

EJNMMI Research|May 9, 2020

Targeted beta therapy of prostate cancer with <sup>177</sup>Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)Mei-Chun Yeh, Brian W C Tse, Nicholas L Fletcher, et al.

BMJ Open|June 16, 2026

Developing general practitioner and consumer supports for genomics in Australian primary care: a mixed-methods protocolJanet C Long, Alison D Archibald, Klay Lamprell, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

The Journal of Experimental Medicine|May 19, 2010

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigensSarah L Jongbloed, Andrew J Kassianos, Kylie J McDonald, et al.

EJNMMI Research|May 9, 2020

Targeted beta therapy of prostate cancer with <sup>177</sup>Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)Mei-Chun Yeh, Brian W C Tse, Nicholas L Fletcher, et al.

BMJ Open|June 16, 2026

Developing general practitioner and consumer supports for genomics in Australian primary care: a mixed-methods protocolJanet C Long, Alison D Archibald, Klay Lamprell, et al.

Pageof 3